EFTR

eFFECTOR Therapeutics, Inc. Common Stock
EFTR

Overview Fund Activity
Delisted

EFTR was delisted on the 2nd of July, 2024.

Back to rankings

26 hedge funds and large institutions have $9.94M invested in eFFECTOR Therapeutics, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
26
Holders Change
-4
Holders Change %
-13.33%
% of All Funds
0.42%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
5
Increased
3
Reduced
6
Closed
6
Calls
$35K
Puts
–
Net Calls
+$35K
Net Calls Change
-$8K

Top Buyers

1
CG
1
Carlyle Group
District of Columbia
$1.69M
2
EWA
2
EP Wealth Advisors
California
$1.65M
3
SOA
3
Sea Otter Advisors
Florida
$93.1K
4
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$22.5K
5
TSS
5
Two Sigma Securities
New York
$8.69K

Top Sellers

1
Corient Private Wealth
1
Corient Private Wealth
Florida
$0
2
Renaissance Technologies
2
Renaissance Technologies
New York
$51K
3
IDA
3
Intelligence Driven Advisers
California
$0
4
Two Sigma Investments
4
Two Sigma Investments
New York
$0
5
Millennium Management
5
Millennium Management
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Wells Fargo
26
Wells Fargo
California
$26 – – –
Corient Private Wealth
27
Corient Private Wealth
Florida
– -$118K -11,018 Closed
IDA
28
Intelligence Driven Advisers
California
– -$24.4K -1,951 Closed
Two Sigma Investments
29
Two Sigma Investments
New York
– -$16.5K -1,543 Closed
Millennium Management
30
Millennium Management
New York
– -$9K -844 Closed
Simplex Trading
31
Simplex Trading
Illinois
– -$3K -344 Closed
Morgan Stanley
32
Morgan Stanley
New York
– -$2.57K -240 Closed
1
2